Aurinia Pharmaceuticals (AUPH) EBIT Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,386.07% |
| 10 | Aurinia Pharmaceuticals | 2.03 Bn | 1.65 Bn | 71.20 Mn | 89.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 89.60% |
| Dec 31, 2025 | 2,091.55% |
| Sep 30, 2025 | 153.19% |
| Jun 30, 2025 | 1,427.36% |
| Mar 31, 2025 | 264.85% |
| Dec 31, 2024 | 94.38% |
| Sep 30, 2024 | 172.24% |
| Jun 30, 2024 | 90.64% |
| Mar 31, 2024 | 55.20% |
| Dec 31, 2023 | -5.60% |
| Sep 30, 2023 | -71.21% |
| Jun 30, 2023 | 55.07% |
| Mar 31, 2023 | 21.90% |
| Dec 31, 2022 | 14.08% |
| Sep 30, 2022 | 81.14% |
| Jun 30, 2022 | 23.65% |
| Mar 31, 2022 | 25.05% |
| Dec 31, 2021 | -306.17% |
| Sep 30, 2021 | -19.00% |
| Jun 30, 2021 | -75.46% |
| Mar 31, 2021 | -86.78% |
| Dec 31, 2020 | 76.89% |
| Sep 30, 2020 | -75.81% |
| Jun 30, 2020 | -56.70% |
| Mar 31, 2020 | -81.72% |
| Dec 31, 2019 | -139.95% |
| Sep 30, 2019 | -33.70% |
| Jun 30, 2019 | -8.69% |
| Mar 31, 2019 | 3.79% |
| Dec 31, 2018 | -335.77% |